ArticleThe journal of pathology. Clinical research2022

The prostate tissue-based telomere biomarker as a prognostic tool for metastasis and death from prostate cancer after prostatectomy.

Christopher M Heaphy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.